Interleukin‐21 differentially affects human natural killer cell subsets
Open Access
- 19 October 2007
- journal article
- Published by Wiley in Immunology
- Vol. 122 (4), 486-495
- https://doi.org/10.1111/j.1365-2567.2007.02675.x
Abstract
Interleukin-21 (IL-21) is a cytokine with pleiotropic effects on various cell types including dendritic cells, B cells, T cells and natural killer (NK) cells. To evaluate if IL-21 affects human NK cell subpopulations in a similar fashion, functional studies were performed on CD56dim and CD56bright NK cells, both bearing IL-21 receptors at identical densities. Stimulation with IL-21 strongly induced proliferation of CD56bright NK cells and cytotoxicity against K562 target cells was preferentially augmented in CD56dim NK cells. In contrast, stimulation with IL-2 and IL-21 alone or in combination failed to induce interferon-γ and tumour necrosis factor-α production in the two NK cell subsets. Intracellular analysis of signal transducer and activator of transcription (STAT) proteins revealed that IL-21 by itself induces phosphorylation of STAT1 and STAT3 in CD56dim NK cells, and to an even higher degree in CD56bright NK cells. In this CD56bright NK cell population alone, IL-2 weakly phosphorylated STAT1 and STAT3, which was further increased when cells were treated with the combination of both cytokines. In contrast, STAT5 was strongly phosphorylated only in CD56bright NK cells by low-dose IL-2, while IL-21 did not affect STAT5 at all. In summary, we present data indicating that the NK-cell-directed cytokines IL-2 and IL-21 not only affect functions in NK cell subpopulations differently but can also act additively.Keywords
This publication has 42 references indexed in Scilit:
- Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cellsJournal of Leukocyte Biology, 2006
- Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiationNature Reviews Immunology, 2005
- Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinomaThe Journal of Gene Medicine, 2005
- Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirusNature Immunology, 2005
- IL-21: a novel IL-2–family lymphokine that modulates B, T, and natural killer cell responsesJournal of Allergy and Clinical Immunology, 2003
- Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effectsCancer Gene Therapy, 2003
- Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cellsNature, 2001
- The Proteasome Regulates Receptor-mediated Endocytosis of Interleukin-2Journal of Biological Chemistry, 2001
- Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.Journal of Clinical Investigation, 1996
- CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.The Journal of Experimental Medicine, 1991